Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
Titel:
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
Auteur:
Van Cutsem, Eric di Bartolomeo, Maria Smyth, Elizabeth Chau, Ian Park, Haeseong Siena, Salvatore Lonardi, Sara Wainberg, Zev A Ajani, Jaffer Chao, Joseph Janjigian, Yelena Qin, Amy Singh, Jasmeet Barlaskar, Ferdous Kawaguchi, Yoshinori Ku, Geoffrey